Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Lanreotide on Volume of Polycystic Liver and Kidney in Autosomal Dominant Polycystic Kidney Disease

NCT01354405 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT01354405
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01354405 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Lanreotide on Volume of Polycystic Liver and Kidney in Autosomal Dominant Polycystic Kidney Disease
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
May 31, 2011
Completion date
June 30, 2014
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

polycystic liver disease